Israel Englander Athira Pharma, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 10,085 shares of ATHA stock, worth $2,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,085
Previous 10,118
0.33%
Holding current value
$2,823
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ATHA
# of Institutions
62Shares Held
18.8MCall Options Held
17.2KPut Options Held
800-
Perceptive Advisors LLC New York, NY5.4MShares$1.51 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.78MShares$777,2471.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$435,8620.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$417,9810.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$417,9810.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $10.6M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...